Our results are consistent with a recent report in which small hairpin RNA and pharmacological inhibitor of TGF-β-activated kinase (TAK)-1 that activates NF-κB was used to sensitize pancreatic cancer to gemcitabine [27]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.